The Protective and Immunomodulatory Effects of Fucoidan Against 7,12-Dimethyl benz[a]anthracene-Induced Experimental Mammary Carcinogenesis Through the PD1/PDL1 Signaling Pathway in Rats

References

• Wang Q, Song Y, He Y, Ren D, Kow F, et al.: Structural characterisation of algae Costaria costata fucoidan and its effects on CCl4-induced liver injury. Carbohydr Polym 107, 247–254, 2014.
   PubMed Web of Science ®Google Scholar
• Hwang PA, Phan NN, Lu WJ, Ngoc Hieu BT, and Lin YC: Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells. Food Nutr Res 60, 32033, 2016.
   PubMed Web of Science ®Google Scholar
• Rabanal M, Ponce NM, Navarro DA, Gómez RM, and Stortz CA: The system of fucoidans from the brown seaweed Dictyota dichotoma: chemical analysis and antiviral activity. Carbohydr Polym 101, 804–811, 2014.
   PubMed Web of Science ®Google Scholar
• Han YS, Lee JH, and Lee SH: Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep 12, 3446–3452, 2015.
   PubMed Web of Science ®Google Scholar
• Zhang J, Riby JE, Conde L, Grizzle WE, Cui X, et al.: A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines. BMC Complement Altern Med 16, 151, 2016.
   PubMed Web of Science ®Google Scholar
• Boo HJ, Hong JY, Kim SC, Kang JI, Kim MK, et al.: The anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar Drugs 11, 2982–2999, 2013.
   PubMed Web of Science ®Google Scholar
• Huang TH, Chiu YH, Chan YL, Chiu YH, Wang H, et al.: Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice. Mar Drugs 13, 1882–1900, 2015.
   PubMed Web of Science ®Google Scholar
• Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, et al.: Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. Biomed Pharmacother 83, 607–616, 2016.
   PubMed Web of Science ®Google Scholar
• Wei C, Xiao Q, Kuang X, Zhang T, Yang Z, et al.: Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species. Mol Med Rep 12, 6649–6655, 2015.
   PubMed Web of Science ®Google Scholar
• Xue M, Ge Y, Zhang J, Wang Q, Hou L, et al.: Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PLoS One 7, e43483, 2012.
   PubMed Web of Science ®Google Scholar
• Linjawi SA, Khalil WK, Hassanane MM, and Ahmed ES: Evaluation of the protective effect of Nigella sativa extract and its primary active component thymoquinone against DMBA-induced breast cancer in female rats. Arch Med Sci 11, 220–229, 2015.
   PubMed Web of Science ®Google Scholar
• Treacy O, O'Flynn L, Ryan AE, Morcos M, Lohan P, et al.: Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation. Am J Transplant 14, 2023–2036, 2014.
   PubMed Web of Science ®Google Scholar
• Ananda Sadagopan SK, Mohebali N, Looi CY, Hasanpourghadi M, Pandurangan AK, et al.: Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo. J Exp Clin Cancer Resc 8, 147, 2015.
   Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, and Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330–336, 2003.
   PubMed Web of Science ®Google Scholar
• Quezada SA, Peggs KS, Simpson TR, and Allison JP: Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol Rev 241, 104–118, 2011.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kusnadi A, Lee EJ, Kim WW, Cho BC, et al.: Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cell Immunol 278, 76–83, 2012.
   PubMed Web of Science ®Google Scholar
• Dai S, Jia R, Zhang X, Fang Q, and Huang L: The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol 290, 72–79, 2014.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhao Y, Zhang Y, and Zhang D: Fucoidan induces cancer cell apoptosis by modulating the endoplasmic reticulum stress cascades. PLoS One 9, e108157, 2014.
   PubMed Web of Science ®Google Scholar
• Roshan S, Liu YY, Banafa A, Chen HJ, Li KX, et al.: Fucoidan induces apoptosis of HepG2 cells by down-regulating p-Stat3. J Huazhong Univ Sci Technolog Med Sci 34, 330–336, 2014.
   PubMed Web of Science ®Google Scholar
• Alwarsamy M, Gooneratne R, and Ravichandran R: Effect of fucoidan from Turbinaria conoides on human lung adenocarcinoma epithelial (A549) cells. Carbohydr Polym 152, 207–213, 2016.
   PubMed Web of Science ®Google Scholar
• Moussavou G, Kwak DH, Obiang-Obonou BW, Maranguy CA, Dinzouna-Boutamba SD, et al.: Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs 12, 4898–4911, 2014.
   PubMed Web of Science ®Google Scholar
• Chen YM, Tsai YH, Tsai TY, Chiu YS, Wei L, et al.: Fucoidan supplementation improves exercise performance and exhibits anti-fatigue action in mice. Nutrients 31, 239–252, 2014.
   Web of Science ®Google Scholar
• Wang P, Liu Z, Liu X, Teng H, Zhang C, et al.: Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells. PLoS One 9, e106071, 2014.
   PubMed Web of Science ®Google Scholar
• Eguizabal C, Zenarruzabeitia O, Monge J, Santos S, Vesga MA, et al.: Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Front Immunol 5, 439, 2014.
   PubMed Web of Science ®Google Scholar
• Jamieson AM, Isnard P, Dorfman JR, Coles MC, and Raulet DH: Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol 172, 864–870, 2004.
   PubMed Web of Science ®Google Scholar
• Wan Y, Ren X, Ren Y, Wang J, Hu Z, et al.: As a genetic adjuvant, CTA improves the immunogenicity of DNA vaccines in an ADP-ribosyltransferase activity- and IL-6-dependent manner. Vaccine 32, 2173–2180, 2014.
   PubMed Web of Science ®Google Scholar
• Kaliński P, Hilkens CM, Snijders A, Snijdewint FG, and Kapsenberg ML: IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2cytokine production in maturing human naive T helper cells. J Immunol 159, 28–35, 1997.
   PubMed Web of Science ®Google Scholar
• Deligne C, Metidji A, Fridman WH, and Teillaud JL: Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in mice. Leukemia 29, 947–957, 2015.
   PubMed Web of Science ®Google Scholar
• Chang MC, Chen YL, Chiang YC, Chen TC, Tang YC, et al.: Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator. Gene Ther 23, 38–49, 2016.
   PubMed Web of Science ®Google Scholar
• Schoenborn JR and Wilson CB: Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96, 41–101, 2007.
   PubMed Web of Science ®Google Scholar
• Xue T, Liu P, Zhou Y, Liu K, Yang L, et al.: Interleukin-6 induced “acute” phenotypic microenvironment promotes Th1 anti-tumor immunity in cryo-thermal therapy revealed by shotgun and parallel reaction monitoring proteomics. Theranostics 6, 773–794, 2016.
   PubMed Web of Science ®Google Scholar
• Jin JO, Zhang W, Du JY, Wong KW, Oda T, et al.: Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses. PLoS One 9, e99396, 2014.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yang R, Li M, Zhou Q, Liang X, et al.: Effects of dietary fucoidan on the blood constituents, anti-oxidation and innate immunity of juvenile yellow catfish (Pelteobagrus fulvidraco). Fish Shellfish Immunol 41, 264–270, 2014.
   PubMed Web of Science ®Google Scholar
• Carvalho MI, Pires I, Prada J, Gregório H, Lobo L, et al.: Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors. Vet Immunol Immunopathol 178, 1–9, 2016.
   PubMed Web of Science ®Google Scholar
• Liu F, Lang R, Zhao J, Zhang X, Pringle GA, et al.: CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 130, 645–655, 2011.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, et al.: Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib. Gastroenterology 150, 1646–1658, 2016.
   PubMed Web of Science ®Google Scholar
• Hossain DM, Panda AK, Manna A, Mohanty S, Bhattacharjee P, et al.: FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39, 1057–1069, 2013.
   PubMed Web of Science ®Google Scholar
• Shen X, Li N, Li H, Zhang T, Wang F, et al.: Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J Cancer Res Clin Oncol 136, 1745–1754, 2010.
   PubMed Web of Science ®Google Scholar
• Hossain DM, Panda AK, Chakrabarty S, Bhattacharjee P, Kajal K, et al.: MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Immunology 144, 561–573, 2015.
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, et al.: Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91, 964–971, 2001.
   PubMed Web of Science ®Google Scholar
• Grau AM, Wen W, Ramroopsingh DS, Gao YT, Zi J, et al.: Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai BreastCancer Study. Breast Cancer Res Treat 112, 335–341, 2008.
   PubMed Web of Science ®Google Scholar
• Berry S and Taube JM: Innate vs. adaptive: PD-L1-mediated immune resistance by melanoma. Oncoimmunology 4, e1029704, 2015.
   PubMed Web of Science ®Google Scholar
• Akbay EA, Koyama S, Carretero J, Altabef A, Tchaicha JH, et al.: Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors. Cancer Discov 3, 1355–1363, 2013.
   PubMed Web of Science ®Google Scholar
• Taube JM, Anders RA, Young GD, Xu H, Sharma R, et al.: Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 4, 127–137, 2012.
   Web of Science ®Google Scholar
• Bertucci F, Finetti P, Birnbaum D, and Mamessier E: The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers. Oncoimmunology 5, e1085148, 2015.
   PubMed Web of Science ®Google Scholar